India has suspended a drugmaker’s manufacturing licence after the World Health Organization flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday. Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has damaged India’s image as the “pharmacy of the world” providing affordable drugs globally.
Recent Posts
- FPIs pull out Rs 35,475 cr this week from Indian markets, March outflows hit Rs 88,180 cr
- Foetus older than 5 months would be treated as ‘person’ in eyes of law,entitled for compensation: HC
- West Asia Conflict:Trump indicates possible end to conflict,Oil price spike continues
- RiverStone International launches Australian presence with company acquisition, leadership appointment and legacy transaction with Zurich
- Safety Management:NHAI to deploy AI powered dashcam monitoring system for 40,000 km of National Highway network
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits